Phi-Medics

Phi-Medics was a private UK pharmaceutical consulting company focused on clinical R&D, medical strategy, medical affairs, and interim management services for pharmaceutical clients. The company was founded and led by Christine Wilkinson Blanc and positioned itself as an experienced external resource for drug development planning, clinical trial design and conduct, regulatory support, and commercialization strategy. Its stated expertise centered on oncology and hematology products, including small molecules, cytotoxics, antibodies, vaccines, radiopharmaceuticals, and diagnostics/imaging. Based on publicly available insolvency notices in early 2026, the company appears to have entered winding-up/liquidation and should be treated as no longer active as an operating business.